VPA

ECARX Unveils Multiple Automotive Intelligence Solutions on Tech Day

Retrieved on: 
Wednesday, March 20, 2024

SHANGHAI, China, March 20, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today held its second Tech Day at the Hangzhou E-Sports Center, where it unveiled several ground-breaking automotive intelligence solutions and ecosystem advancements.

Key Points: 
  • SHANGHAI, China, March 20, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today held its second Tech Day at the Hangzhou E-Sports Center, where it unveiled several ground-breaking automotive intelligence solutions and ecosystem advancements.
  • The Atlas and Pikes computing platforms are powered by the fourth-generation Qualcomm Snapdragon® System-on-a-Chip (SoC), namely SA8255P and SA8295P Snapdragon®, respectively.
  • Integrating both Flyme Auto and Google Automotive Services (GAS), each of the Atlas and Pikes computing platforms will allow ECARX to service automotive OEMs worldwide within a single platform.
  • "ECARX remains at the forefront of technological advancements, leveraging ground-breaking, cross-border technology integration and innovation.

MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor

Retrieved on: 
Thursday, March 21, 2024

MIAMI, March 21, 2024 /PRNewswire/ -- MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), an innovative pre-clinical-stage pharmaceutical company focused on the development of novel treatments for neurologic and neuropsychiatric disorders, proudly announces the appointment of distinguished pharmaceutical executive Dr. Itzchak Angel as its new Chief Scientific Advisor.

Key Points: 
  • Dr. Angel brings over 40 years of preclinical, clinical and regulatory acumen to MIRA.
  • He has significantly contributed to the research, development and regulatory approval of groundbreaking medications over his remarkable career.
  • Additionally, his activities contributed to the development and marketing of Mizollen (mizolastine), Xatral (alfuzosin) and Ambien (zolpidem).
  • "We are truly honored to have Dr. Angel on our team," stated Erez Aminov, Chairman & CEO of MIRA.

ACRES VIDEO POKER ANALYZER CASE STUDY IDENTIFIES PROFITS LOST TO ADVANTAGE PLAYERS

Retrieved on: 
Wednesday, March 20, 2024

LAS VEGAS, March 20, 2024 /PRNewswire/ -- Acres Manufacturing Company (Acres), a leading casino loyalty and technology developer, today released a case study powered by its Video Poker Analyzer ("VPA") product, which reveals the identity and lost-profit impact of highly skilled video poker players, known to the industry as Advantage Players ("APs").  The case study, which is based on the evaluation of over three million hands played by over one thousand identified carded players, highlights the ability of a small population of APs to reliably beat the casino and attract a disproportionate share of loyalty program offers.

Key Points: 
  • LAS VEGAS, March 20, 2024 /PRNewswire/ -- Acres Manufacturing Company (Acres), a leading casino loyalty and technology developer, today released a case study powered by its Video Poker Analyzer ("VPA") product, which reveals the identity and lost-profit impact of highly skilled video poker players, known to the industry as Advantage Players ("APs").
  • VPA's analysis of video poker play at a Las Vegas locals casino with heavy video poker play found that APs make up roughly 1% of the casino's player population.
  • Collectively, these players caused a loss to the casino equivalent to 25.64% of its carded win on video poker during the period of the study.
  • Video Poker Analyzer is powered by Acres' Foundation™ hardware, which is compatible with any modern slot machine and any casino management system.

SOLRITE Energy Disrupts the PPA Industry with First-of-Its-Kind Virtual Power Plant Power Purchase Agreement

Retrieved on: 
Thursday, February 8, 2024

SAN MARCOS, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- SOLRITE Energy , a PPA provider with an emphasis on solar plus storage solutions, has partnered with sonnen , a global market leader in smart energy storage and VPP technology, to launch the SOLRITE Virtual Power Plant Power Purchase Agreement (VPA).

Key Points: 
  • SAN MARCOS, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- SOLRITE Energy , a PPA provider with an emphasis on solar plus storage solutions, has partnered with sonnen , a global market leader in smart energy storage and VPP technology, to launch the SOLRITE Virtual Power Plant Power Purchase Agreement (VPA).
  • The SOLRITE VPA represents the industry’s first PPA offering that leverages grid services provided by the sonnenConnect VPP Program.
  • Through this unique VPA, SOLRITE aims to introduce solar + storage to more customer segments, including homeowners who have previously been unable to qualify for financing.
  • ​In markets where grid services and VPP programs are not yet available, SOLRITE will continue to offer competitive PPA financing options for eligible customers.

China Passenger Car Driving-parking Integrated Solution Industry Report 2023: With the Declining Share of the Self-development Model, Suppliers' Solutions Blossom - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 3, 2024

The "China Passenger Car Driving-parking Integrated Solution Industry Report, 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Passenger Car Driving-parking Integrated Solution Industry Report, 2023" report has been added to ResearchAndMarkets.com's offering.
  • Research on driving-parking integration: with the declining share of the self-development model, suppliers' solutions blossom.
  • For example, Aptiv's driving-parking integrated solution launched in April 2023 can be divided into Core and Pro versions by configuration.
  • Hong Jing Drive's driving-parking integrated solution introduced in December 2022 is based on one J3 chip and supports 5R5V12U.

The CVPA Brings The Veterinary Shortage Crisis Situation To The Forefront

Retrieved on: 
Tuesday, December 19, 2023

WIMBERLEY, Texas, Dec. 19, 2023 /PRNewswire/ -- The Coalition for the Veterinary Professional Associate (CVPA) brings the veterinary shortage crisis to the forefront with a wake-up call for the animal healthcare industry. The CVPA is composed of many veterinary industry professionals who have dedicated their lives to the animal healthcare industry for many years, and we have watched the veterinary shortage bring our industry to an abyss, having far-reaching effects from food animal to shelter medicine and everything in between. National, Regional, State, and local news agencies have broadcast, printed, and blogged about the veterinarian and veterinary technician shortage for years (to view news articles, click here).

Key Points: 
  • WIMBERLEY, Texas, Dec. 19, 2023 /PRNewswire/ -- The Coalition for the Veterinary Professional Associate (CVPA) brings the veterinary shortage crisis to the forefront with a wake-up call for the animal healthcare industry.
  • The animal healthcare industry has been facing an alarming issue for many years - the veterinary shortage crisis.
  • The most significant contributor to this crisis is the industry's shortage of veterinarians and veterinary technicians.
  • The AVMA House of Delegates will discuss veterinary workforce issues at the Veterinary Leadership Conference in early January 2024.

Webscale Acquires Section.io to Launch CloudFlow: An AI-Based Platform For Smart Distributed Computing and Cloud Cost Control

Retrieved on: 
Thursday, October 19, 2023

CloudFlow empowers businesses, from Independent Software Vendors (ISVs) to enterprise organizations, to harness the full potential of AI to drive deep levels of efficiency into their distributed cloud computing strategies.

Key Points: 
  • CloudFlow empowers businesses, from Independent Software Vendors (ISVs) to enterprise organizations, to harness the full potential of AI to drive deep levels of efficiency into their distributed cloud computing strategies.
  • Zero-Ops Simplicity: By utilizing CloudFlow, zero-ops distributed cloud computing becomes an immediate reality, saving organizations time, effort, and resources.
  • "The acquisition of Section.io by Webscale signifies a pivotal moment in cloud-native computing," said Gary Schofield, CEO of Webscale.
  • Under the united Webscale banner, we're poised to redefine the future of digital experiences, setting new standards for smart distributed computing and cloud infrastructure cost control.

BOSE ANNOUNCES NEW QUIETCOMFORT ULTRA HEADPHONES AND EARBUDS WITH BOSE IMMERSIVE AUDIO FOR THE MOST REALISTIC SOUND EVER

Retrieved on: 
Thursday, September 14, 2023

And now, the QC Ultra Headphones and Earbuds both feature an all-new premium design and debut Bose Immersive Audio, taking audio performance to an entirely new level.

Key Points: 
  • And now, the QC Ultra Headphones and Earbuds both feature an all-new premium design and debut Bose Immersive Audio, taking audio performance to an entirely new level.
  • The QuietComfort Ultra Headphones and QuietComfort Ultra Earbuds will be available beginning early October for $429 and $299 respectively.
  • "The QuietComfort Ultra Headphones and Earbuds with Bose Immersive Audio won't disappoint.
  • The QuietComfort Ultra Headphones, QuietComfort Ultra Earbuds, and QuietComfort Headphones work with a mobile device's built-in voice assistant and use the Bose Music app for additional features like shortcut settings, listening modes, and adjustable EQ.

Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment

Retrieved on: 
Tuesday, August 15, 2023

CBD is an FDA-approved treatment for seizures in patients diagnosed with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex.

Key Points: 
  • CBD is an FDA-approved treatment for seizures in patients diagnosed with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex.
  • During the pre-approval clinical trials, treatment with CBD was occasionally associated with elevation in blood levels of ALT, a marker of liver injury, but this was much more common in patients already receiving treatment with VPA for seizures.
  • To identify potential underlying mechanisms, researchers used DILIsym to predict ALT levels in simulated populations that were treated with CBD alone, treated with VPA alone, and then treated with VPA before they were treated with CBD.
  • DILIsym predicted dose-dependent ALT elevations for CBD treatment and ALT elevations for VPA treatment when each was given alone, but the combined VPA and CBD treatment protocol mimicking the clinical trials did not increase the incidence of ALT elevations relative to CBD treatment on its own.

Latest news - 6th EU-Vietnam Interparliamentary Meeting, Hanoi, 19 to 21 June 2023 - Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN)

Retrieved on: 
Thursday, June 29, 2023

6th EU-Vietnam Interparliamentary Meeting, Hanoi, 19 to 21 June 2023

Key Points: 
  • 6th EU-Vietnam Interparliamentary Meeting, Hanoi, 19 to 21 June 2023
    28-06-2023 - 17:25
    The 6th EU-Viet Nam Inter-Parliamentary Meeting (IPM) was held in Ha Noi, Viet Nam, on 19-21 June.
  • The European Parliament Delegation to the IPM was lead by MEP Daniel CASPARY, Chair of the Delegation for relations with Southeast Asia and ASEAN.
  • Matters of common interest were discussed such as Russia's war on Ukraine, the EU- Viet Nam Free Trade Agreement (EVFTA), the EU- Viet Nam Investment Protection Agreement (IPA), Illegal, Unreported and Unregulated (IUU) fishing, the EU-Viet Nam Just Energy Partnership, and the EU- Viet Nam Voluntary Partnership Agreement (VPA) on Forest Law Enforcement, Governance and Trade (FLEGT), as well as infrastructure needs of Viet Nam's economy.